Biodexa Pharmaceticals Stock Filter Stocks by Fundamentals
BDRX Stock | 5.62 0.69 14.00% |
Biodexa Pharmaceticals fundamentals help investors to digest information that contributes to Biodexa Pharmaceticals' financial success or failures. It also enables traders to predict the movement of Biodexa Stock. The fundamental analysis module provides a way to measure Biodexa Pharmaceticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Biodexa Pharmaceticals stock.
Biodexa | Cash and Equivalents |
Did you try this?
Run Positions Ratings Now
Positions RatingsDetermine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |
All Next | Launch Module |
Biodexa Fundamentals
Return On Equity | -0.97 | ||||
Return On Asset | -0.38 | ||||
Operating Margin | (79.31) % | ||||
Current Valuation | (3.01 M) | ||||
Shares Outstanding | 580.84 K | ||||
Shares Owned By Insiders | 10.16 % | ||||
Shares Owned By Institutions | 37.51 % | ||||
Number Of Shares Shorted | 16 K | ||||
Price To Book | 0.26 X | ||||
Price To Sales | 34.50 X | ||||
Revenue | 381 K | ||||
Gross Profit | (4.41 M) | ||||
EBITDA | (7.16 M) | ||||
Net Income | (7.08 M) | ||||
Total Debt | 464 K | ||||
Book Value Per Share | 24.07 X | ||||
Cash Flow From Operations | (6.83 M) | ||||
Short Ratio | 0.04 X | ||||
Earnings Per Share | (75.43) X | ||||
Target Price | 156.43 | ||||
Number Of Employees | 21 | ||||
Beta | 1.44 | ||||
Market Capitalization | 2.86 M | ||||
Total Asset | 10.54 M | ||||
Retained Earnings | (144.77 M) | ||||
Working Capital | 1.46 M | ||||
Net Asset | 10.54 M |
About Biodexa Pharmaceticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Biodexa Pharmaceticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biodexa Pharmaceticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biodexa Pharmaceticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Biodexa Stock Analysis
When running Biodexa Pharmaceticals' price analysis, check to measure Biodexa Pharmaceticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biodexa Pharmaceticals is operating at the current time. Most of Biodexa Pharmaceticals' value examination focuses on studying past and present price action to predict the probability of Biodexa Pharmaceticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biodexa Pharmaceticals' price. Additionally, you may evaluate how the addition of Biodexa Pharmaceticals to your portfolios can decrease your overall portfolio volatility.